Results of two Phase 1, Randomized, Double-blind, Placebo-controlled, Studies (Ascending Single-dose and Multiple-dose Studies) to Determine the Safety, Tolerability, and Pharmacokinetics of Orally Administered LX9211 in Healthy Participants

Autor: Bundrant, LuAnn *, Hunt, Thomas L. *, Banks, Phil, Gopinathan, Suma, Boehm, Kristi A., Kassler-Taub, Kenneth, Tyle, Praveen, Wilson, Alan, Warner, Chris, Wason, Suman *
Zdroj: In Clinical Therapeutics June 2021 43(6):1029-1050
Databáze: ScienceDirect
Externí odkaz: